Our laboratory provides a wide range of DNA and RNA based tests for infectious diseases, solid tumor mutation marker study, and hematologic malignancies. One of our primary strengths is specific types of solid tumor and leukemias. DxFLEX is a new clinical flow cytometry platform derived from the successful CytoFLEX. LabQuest has been using this technology extensively for the detection of many cancer markers, such as- CD4 count, CD8 count, PNH clones, CLPD, etc.